TickerFacts.

A business in context

INCY research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-31 · 0000879169-26-000058 · Items 8.01

  2. 4 · Ownership change

    Report date 2026-08-25 · 0002083591-26-000007

  3. 4 · Ownership change

    Report date 2026-08-19 · 0001205703-26-000028

  4. 4 · Ownership change

    Report date 2026-08-12 · 0001205703-26-000027

  5. 4 · Ownership change

    Report date 2026-08-05 · 0002079962-26-000015

  6. 4 · Ownership change

    Report date 2026-08-05 · 0001205703-26-000025

  7. 4 · Ownership change

    Report date 2026-07-31 · 0002079962-26-000013

  8. 4 · Ownership change

    Report date 2026-07-31 · 0001205703-26-000023

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000879169-26-000056

  10. 8-K · Current report

    Report date 2026-07-28 · 0000879169-26-000053 · Items 2.02,9.01

  11. 4 · Ownership change

    Report date 2026-07-23 · 0002039219-26-000008

  12. 8-K · Current report

    Report date 2026-07-06 · 0000879169-26-000048 · Items 8.01,9.01

  13. 8-K · Current report

    Report date 2026-06-22 · 0000879169-26-000046 · Items 8.01

  14. 8-K · Current report

    Report date 2026-06-08 · 0000879169-26-000043 · Items 5.07

  15. 8-K · Current report

    Report date 2026-06-08 · 0000879169-26-000040 · Items 8.01

  16. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0000879169-26-000031

  17. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000879169-26-000026

  18. 8-K · Current report

    Report date 2026-04-28 · 0000879169-26-000023 · Items 2.02

  19. 8-K · Current report

    Report date 2026-03-26 · 0000879169-26-000018 · Items 5.02

  20. 8-K · Current report

    Report date 2026-03-25 · 0000879169-26-000016 · Items 5.02,9.01

  21. 8-K · Current report

    Report date 2026-02-27 · 0000879169-26-000013 · Items 8.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0000879169-26-000010

  23. 8-K · Current report

    Report date 2026-02-10 · 0000879169-26-000006 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-12-10 · 0000879169-25-000122 · Items 5.02

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000879169-25-000118

  26. 8-K · Current report

    Report date 2025-10-28 · 0000879169-25-000115 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-09-30 · 0001104659-25-096632 · Items 5.02

  28. 8-K · Current report

    Report date 2025-08-04 · 0000879169-25-000108 · Items 5.02

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000879169-25-000103

  30. 8-K · Current report

    Report date 2025-07-29 · 0000879169-25-000100 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-06-23 · 0001104659-25-063675 · Items 5.02,9.01

  32. 8-K · Current report

    Report date 2025-06-10 · 0000879169-25-000062 · Items 5.02,5.07,9.01

  33. 8-K · Current report

    Report date 2025-05-11 · 0000879169-25-000059 · Items 8.01

  34. DEF 14A · Proxy statement

    Report date 2025-06-10 · 0001104659-25-041209

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000879169-25-000056

  36. 8-K · Current report

    Report date 2025-04-29 · 0000879169-25-000053 · Items 2.02,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-004633

  38. 8-K · Current report

    Report date 2025-02-10 · 0001628280-25-004514 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-01-06 · 0000879169-25-000011 · Items 5.02

  40. SC 13G · Ownership disclosure

    0002012383-24-004022

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 27 transaction rows27AExercise / conversion: 15 transaction rows15MTax / exercise payment: 2 transaction rows2FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

48 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-08
2026-06-10
High Katherine AA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
High Katherine AA · Grant / award
Acquired
Non Qualfied Stock Option (right to buy)
Derivative security
6111.00.0
2026-06-08
2026-06-10
Clancy Paul JA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
Clancy Paul JA · Grant / award
Acquired
Non Qualfied Stock Option (right to buy)
Derivative security
6111.00.0
2026-06-08
2026-06-10
FOUSE JACQUALYN AA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
FOUSE JACQUALYN AA · Grant / award
Acquired
Non Qualfied Stock Option (right to buy)
Derivative security
6111.00.0
2026-06-08
2026-06-10
BIENAIME JEAN JACQUESA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
BIENAIME JEAN JACQUESA · Grant / award
Acquired
Non Qualfied Stock Option (right to buy)
Derivative security
6111.00.0
2026-06-08
2026-06-10
BRAWLEY OTIS WA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
BRAWLEY OTIS WA · Grant / award
Acquired
Non Qualfied Stock Option (right to buy)
Derivative security
6111.00.0
2026-06-08
2026-06-10
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Non-Qualified Stock Options (right to buy)
Derivative security
6111.00.0
2026-06-08
2026-06-10
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Non-Qualified Stock Options (right to buy)
Derivative security
6111.00.0
2026-06-08
2026-06-10
HARRIGAN EDMUNDA · Grant / award
Acquired
Common Stock1642.00.0
2026-06-08
2026-06-10
HARRIGAN EDMUNDA · Grant / award
Acquired
Non Qualfied Stock Option (right to buy)
Derivative security
6111.00.0
2026-06-04
2026-06-08
Tray Thomas
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2639.0100.0
2026-06-04
2026-06-08
Tray Thomas
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock2639.083.83
2026-06-04
2026-06-08
Tray Thomas
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (right to buy)
Derivative security
2639.00.0
2026-06-01
2026-06-03
CAGNONI PABLO JF · Tax / exercise payment
Disposed
Common Stock25469.095.59
2026-05-26
2026-05-28
Tray Thomas
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2051.097.35
2026-05-26
2026-05-28
BIENAIME JEAN JACQUES
10b5-1 checkbox reported
F · Tax / exercise payment
Disposed
Common Stock13059.097.1
2026-05-26
2026-05-28
BIENAIME JEAN JACQUES
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock15000.084.53
2026-05-26
2026-05-28
BIENAIME JEAN JACQUES
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (right to buy)
Derivative security
15000.00.0
2026-05-19
2026-05-21
Clancy Paul J
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15000.094.93
2026-05-19
2026-05-21
Clancy Paul J
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock15000.084.53
2026-05-19
2026-05-21
Clancy Paul J
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (right to buy)
Derivative security
15000.00.0
2026-05-08
2026-05-11
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPM · Exercise / conversion
Acquired
Common Stock15000.084.53
2026-05-08
2026-05-11
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPM · Exercise / conversion
Acquired
Common Stock15000.084.53
2026-05-08
2026-05-11
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPM · Exercise / conversion
Disposed
Non-Qualified Stock Options
Derivative security
15000.00.0
2026-05-08
2026-05-11
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPM · Exercise / conversion
Disposed
Non-Qualified Stock Options
Derivative security
15000.00.0
2026-05-06
2026-05-20 · Amendment
Stein Steven HA · Grant / award
Acquired
Common Stock44124.00.0
2026-05-06
2026-05-20 · Amendment
CAGNONI PABLO JA · Grant / award
Acquired
Common Stock31517.00.0
2026-05-04
2026-05-06
Upadhyay SuketuA · Grant / award
Acquired
Common Stock26343.00.0
2026-05-04
2026-05-06
Upadhyay SuketuA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
38429.00.0
2026-05-04
2026-05-06
Upadhyay SuketuA · Grant / award
Acquired
Performance Shares
Derivative security
13171.00.0
2026-04-17
2026-04-21
CAGNONI PABLO J
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock6077.064.25
2026-04-17
2026-04-21
CAGNONI PABLO J
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock18667.096.5
2026-04-17
2026-04-21
CAGNONI PABLO J
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock12590.071.93
2026-04-17
2026-04-21
CAGNONI PABLO J
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
6077.00.0
2026-04-17
2026-04-21
CAGNONI PABLO J
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (right to buy)
Derivative security
12590.00.0
2026-04-15
2026-04-17
Stein Steven HA · Grant / award
Acquired
Common Stock39049.00.0
2026-04-15
2026-04-17
Meury WilliamM · Exercise / conversion
Acquired
Common Stock125000.00.0
2026-04-15
2026-04-17
CAGNONI PABLO JA · Grant / award
Acquired
Common Stock27892.00.0
2026-03-31
2026-04-02
Clancy Paul JA · Grant / award
Acquired
Common Stock265.094.12
2026-03-31
2026-04-02
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Common Stock421.00.0
2026-03-31
2026-04-02
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Common Stock421.00.0
2026-03-31
2026-04-02
HARRIGAN EDMUNDA · Grant / award
Acquired
Common Stock269.094.12

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000879169INCYTE CORP

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300Z4WN6JVZ3T4680
GLEIF legal name
INCYTE CORPORATION
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2023-08-04T17:38:19Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Incyte · alias · wikidata
  • Incyte Corporation · alias · wikidata
  • Incyte Inc. · alias · wikidata
  • INCYTE INC · former SEC name · 2003-03-28 to 2003-03-28
  • INCYTE GENOMICS INC · former SEC name · 2000-08-03 to 2003-02-25
  • INCYTE PHARMACEUTICALS INC · former SEC name · 1994-06-07 to 2000-04-18
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$4.24B$4.51B
2023-12-31$3.70B$4.05B
2022-12-31$3.39B$3.87B
2021-12-31$2.99B$3.68B
2020-12-31$2.67B$3.44B
2019-12-31$2.16B$2.82B
2018-12-31$1.88B$2.50B
2017-12-31$1.54B$2.09B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗